1. Home
  2. IIPR vs OGN Comparison

IIPR vs OGN Comparison

Compare IIPR & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innovative Industrial Properties Inc.

IIPR

Innovative Industrial Properties Inc.

HOLD

Current Price

$50.97

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$8.83

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIPR
OGN
Founded
2016
1923
Country
United States
United States
Employees
23
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
IIPR
OGN
Price
$50.97
$8.83
Analyst Decision
Hold
Hold
Analyst Count
3
4
Target Price
$45.00
$11.75
AVG Volume (30 Days)
242.3K
3.6M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
15.18%
1.16%
EPS Growth
N/A
N/A
EPS
N/A
0.72
Revenue
N/A
$6,216,000,000.00
Revenue This Year
$2.69
$0.42
Revenue Next Year
$3.80
$1.67
P/E Ratio
$10.92
$9.60
Revenue Growth
N/A
N/A
52 Week Low
$44.58
$5.69
52 Week High
$59.83
$13.25

Technical Indicators

Market Signals
Indicator
IIPR
OGN
Relative Strength Index (RSI) 49.17 74.83
Support Level $48.01 $8.32
Resistance Level $51.68 $9.79
Average True Range (ATR) 1.38 0.42
MACD -0.21 0.26
Stochastic Oscillator 48.68 96.82

Price Performance

Historical Comparison
IIPR
OGN

About IIPR Innovative Industrial Properties Inc.

Innovative Industrial Properties Inc is a real estate investment trust focused on the acquisition, ownership and management of specialized industrial and commercial properties in the United States. Its properties are prominently leased to state-licensed operators for their regulated cannabis facilities. The company conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by its Operating Partnership, directly or through subsidiaries. Its segments are: Cannabis Portfolio and Life Science Portfolio, with the majority of revenue coming from the Cannabis Portfolio segment, which involves acquiring, developing, and leasing real estate to regulated cannabis operators on long-term triple-net leases.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: